A number of amphiphilic cyclic peptides—[FR]4, [WR]5, and [WK]5—containing hydrophobic and positively-charged amino acids were synthesized by Fmoc/tBu solid-phase peptide methods and evaluated for their efficiency in intracellular delivery of siRNA to triple-negative breast cancer cell lines, MDA-MB-231 and MDA-MB-468, in the presence and absence of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). Among the peptides, [WR]5, which contains alternate tryptophan (W) and arginine (R) residues, was found to be the most efficient in the delivery of siRNA by improving the delivery by more than 3-fold when compared to other synthesized cyclic peptides that were not efficient. The data also showed that co-formulation of [WR]5 with l...
Gene therapy has gained increasing attention as an alternative to pharmacotherapy for treatment of v...
A series of cyclic peptides, [(DipR)(WR)4], [(DipR)2(WR)3], [(DipR)3(WR)2], [(DipR)4(WR)], and [DipR...
International audienceAbstract Recently, we designed novel amphipathic cell-penetrating peptides, ca...
A number of amphiphilic cyclic peptides—[FR]4, [WR]5, and [WK]5—containing hydrophobic and positivel...
A number of amphiphilic cyclic peptides—[FR]4, [WR]5, and [WK]5—containing hydrophobic and positivel...
A number of amphiphilic cyclic peptides—[FR]4, [WR]5, and [WK]5—containing hydrophobic and positivel...
Amphiphilic cyclic cell-penetrating peptides composed of an increasing number of alternative tryptop...
A number of cyclic peptides containing a positively charged ring composed of arginine residues attac...
A number of cyclic peptides containing a positively charged ring composed of arginine residues attac...
A number of cyclic peptides containing a positively charged ring composed of arginine residues attac...
International audienceSmall interfering RNAs (siRNAs) can down-regulate the expression of a target m...
Delivering siRNA is challenging due to many obstacles, such as extremely short in vivo half-life, ra...
An efficient and safe delivery carrier is required for the therapeutic application of siRNA. In this...
RNA interference (RNAi) has drawn enormous attention as a powerful tool because of its capability to...
Post-transcriptional gene silencing (PTGS), also termed as RNA interference (RNAi) possess a great t...
Gene therapy has gained increasing attention as an alternative to pharmacotherapy for treatment of v...
A series of cyclic peptides, [(DipR)(WR)4], [(DipR)2(WR)3], [(DipR)3(WR)2], [(DipR)4(WR)], and [DipR...
International audienceAbstract Recently, we designed novel amphipathic cell-penetrating peptides, ca...
A number of amphiphilic cyclic peptides—[FR]4, [WR]5, and [WK]5—containing hydrophobic and positivel...
A number of amphiphilic cyclic peptides—[FR]4, [WR]5, and [WK]5—containing hydrophobic and positivel...
A number of amphiphilic cyclic peptides—[FR]4, [WR]5, and [WK]5—containing hydrophobic and positivel...
Amphiphilic cyclic cell-penetrating peptides composed of an increasing number of alternative tryptop...
A number of cyclic peptides containing a positively charged ring composed of arginine residues attac...
A number of cyclic peptides containing a positively charged ring composed of arginine residues attac...
A number of cyclic peptides containing a positively charged ring composed of arginine residues attac...
International audienceSmall interfering RNAs (siRNAs) can down-regulate the expression of a target m...
Delivering siRNA is challenging due to many obstacles, such as extremely short in vivo half-life, ra...
An efficient and safe delivery carrier is required for the therapeutic application of siRNA. In this...
RNA interference (RNAi) has drawn enormous attention as a powerful tool because of its capability to...
Post-transcriptional gene silencing (PTGS), also termed as RNA interference (RNAi) possess a great t...
Gene therapy has gained increasing attention as an alternative to pharmacotherapy for treatment of v...
A series of cyclic peptides, [(DipR)(WR)4], [(DipR)2(WR)3], [(DipR)3(WR)2], [(DipR)4(WR)], and [DipR...
International audienceAbstract Recently, we designed novel amphipathic cell-penetrating peptides, ca...